60 Degrees Pharmaceuticals
SXTP60 Degrees Pharmaceuticals, Inc. (NASDAQ: SXTP) is a United States-based biopharmaceutical company. Its primary business focus is the development and commercialization of medicines for infectious diseases. The company's initial strategic emphasis is on addressing unmet medical needs in tropical diseases, with malaria as a key therapeutic area. The company's lead product is Tafenoquine, marketed under the name ARAKODA®. ARAKODA® is approved by the U.S. Food and Drug Administration (FDA) for the prophylaxis of malaria in adults. Beyond this commercial asset, the company's pipeline includes development programs for other anti-infective indications. 60 Degrees Pharmaceuticals operates as a public entity, and its common stock is traded on the NASDAQ Capital Market under the ticker symbol SXTP.
SXTP · Stock Price
Historical price data
About
60 Degrees Pharmaceuticals, Inc. (NASDAQ: SXTP) is a United States-based biopharmaceutical company. Its primary business focus is the development and commercialization of medicines for infectious diseases. The company's initial strategic emphasis is on addressing unmet medical needs in tropical diseases, with malaria as a key therapeutic area. The company's lead product is Tafenoquine, marketed under the name ARAKODA®. ARAKODA® is approved by the U.S. Food and Drug Administration (FDA) for the prophylaxis of malaria in adults. Beyond this commercial asset, the company's pipeline includes development programs for other anti-infective indications. 60 Degrees Pharmaceuticals operates as a public entity, and its common stock is traded on the NASDAQ Capital Market under the ticker symbol SXTP.